JPH0285260A - Production of imidazole derivative - Google Patents

Production of imidazole derivative

Info

Publication number
JPH0285260A
JPH0285260A JP1114018A JP11401889A JPH0285260A JP H0285260 A JPH0285260 A JP H0285260A JP 1114018 A JP1114018 A JP 1114018A JP 11401889 A JP11401889 A JP 11401889A JP H0285260 A JPH0285260 A JP H0285260A
Authority
JP
Japan
Prior art keywords
compound
formula
group
lower alkyl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1114018A
Other languages
Japanese (ja)
Other versions
JPH0567623B2 (en
Inventor
Tsutomu Terachi
寺地 務
Yoshiharu Nakai
中井 芳治
John Durant Graham
グラハム・ジョン・デュラント
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to JP1114018A priority Critical patent/JPH0285260A/en
Publication of JPH0285260A publication Critical patent/JPH0285260A/en
Publication of JPH0567623B2 publication Critical patent/JPH0567623B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

PURPOSE: To advantageously obtain an imidazole derivative by reacting, e.g. a compound such as N,N'-dicyano-N"-[2-(5-methylimidazol-4-ylmethylthio) ethyl]guanidine with a compound such as methylamine.
CONSTITUTION: A compound of formula I [wherein R1 is lower alkyl; R2 and R3 are each lower alkylene; X1 is a halogen, mercapto, cyanamido, a nitrogen- containing 5-membered aromatic heterocyclic-N-yl group, or a group of formula II (wherein Z is hydroxyl or alkyl; n is 1 or 2)] is reacted with a compound of formula III (wherein R4 is lower alkyl) in a solvent such as methanol usually under cooling or at a temperature up to room temperature to obtain a compound of formula IV. Further, when a compound of formula I wherein X1 is a halogen, a sulfino-group or a sulfo-group is used as the starting material, it is preferred to carry out the reaction in the presence of a base such as triethylamine, pyridine, etc. Also, when a compound of formula I wherein X1 is a mercapto group is used as the starting material, it is preferred to carry out the reaction in the presence of a compound of a heavy metal such as mercury, etc.
COPYRIGHT: (C)1990,JPO

Description

【発明の詳細な説明】 この発明は一般式 (式中、R1およびR4は低級アルキルMl”およびR
3は低級アルキレン基をそれぞれ色味ずろ)で示される
イミダゾール誘導体またはその塩の新規な製造法に関す
るものであり、これを式で示すと次の通りである。
DETAILED DESCRIPTION OF THE INVENTION This invention is based on the general formula (wherein R1 and R4 are lower alkyl Ml" and R
No. 3 relates to a novel method for producing imidazole derivatives or salts thereof, in which the lower alkylene groups are represented by different colors, and the formula is as follows.

[式中、R1、n*、R3およびR4は前と同じ意味で
あり、xlはハロゲン、メルカプト基、窒素含有5員芳
呑複累環−N−イル基または式5−(0)n−Z(ここ
でZはヒドロキン基またはアルキル基、nは1または2
をそれぞれ意味する) で示される基をそれぞれ意味する] この発明の方法は化合物(II)に化合物(1)を作用
させることにより行なわれる。
[In the formula, R1, n*, R3 and R4 have the same meanings as before, and xl is a halogen, a mercapto group, a nitrogen-containing 5-membered aromatic complex ring -N-yl group, or a group of the formula 5-(0)n- Z (where Z is a hydroquine group or an alkyl group, n is 1 or 2
The method of the present invention is carried out by reacting compound (II) with compound (1).

原料化合物(11)において、R’で表わされる低級ア
ルキル基としては、メチル、エチル、プロピル、イソプ
ロピル、ブチル、イソブチル、第3級ブチル、ペンチル
、ヘキシル等の直鎖状らしくは分枝鎖状のアルキル基が
挙げられ、またR’およびR3で表わされる低級アルキ
レン基としてはメチレン、エチレン、トリメチレン、テ
トラメチレン、ペンタメチレン、ヘキサメチレン、2−
メチルトリメチレン、2.2−ジメチルトリメチレン等
の直鎖状もしくは分枝鎖状のアルキレン基が挙げられ、
R1およびR3の低級アルキレン基は同一であっても異
なっていてもよい。
In the starting compound (11), the lower alkyl group represented by R' may be a linear or branched group such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiary butyl, pentyl, hexyl, etc. Examples of lower alkylene groups represented by R' and R3 include methylene, ethylene, trimethylene, tetramethylene, pentamethylene, hexamethylene, 2-
Linear or branched alkylene groups such as methyltrimethylene and 2,2-dimethyltrimethylene are mentioned,
The lower alkylene groups of R1 and R3 may be the same or different.

もう一方の原料化合物(1)においてR4で表わされる
低級アルキル基としては、前記のR1の低級アルキル基
と同様な基が例示される。またxiで表わされるハロゲ
ンとしてはクロル、ブロム、ヨード等が、窒素含n5員
芳香複累環−N〜イル基としては1−ピラゾリル、!−
イミダゾリル、1−ピロリル、1,2.3−トリアゾー
ル−1−イル、3.5−ツメチル−1−ピラゾリル、1
.2゜4−トリアゾール−4−イル等が、式−5(0)
nZで表わされる基としてはスルフィノ基、スルホ基、
メチルスルフィニル、エチルスルフィニル、プロピルス
ルフィニル、イソプロピルスルフィニル、ブチルスルフ
ィニル、イソブチルスルフィニル、第3級ブチルスルフ
ィニル、ペンチルスルフィニル、ヘキシルスルフィニル
等のアルキルスルフィニル基およびメチルスルホニル、
エチルスルホニル、プロピルスルボニル、イソプロピル
スルホニル、ブチルスルホニル、イソブチルスルホニル
、第3級ブチルスルホニル、ペンデルスルホニル、ヘキ
シルスルホニル等のアルキルスルホニル基が例示される
Examples of the lower alkyl group represented by R4 in the other raw material compound (1) include the same groups as the lower alkyl group of R1 described above. Further, the halogen represented by xi includes chlorine, bromo, iodo, etc., and the nitrogen-containing n5-membered aromatic complex -N~yl group includes 1-pyrazolyl,! −
imidazolyl, 1-pyrrolyl, 1,2,3-triazol-1-yl, 3,5-tumethyl-1-pyrazolyl, 1
.. 2゜4-triazol-4-yl etc., formula-5(0)
Groups represented by nZ include sulfino group, sulfo group,
Alkylsulfinyl groups such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, butylsulfinyl, isobutylsulfinyl, tertiary butylsulfinyl, pentylsulfinyl, hexylsulfinyl, and methylsulfonyl;
Examples include alkylsulfonyl groups such as ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, isobutylsulfonyl, tertiary butylsulfonyl, pendelsulfonyl, and hexylsulfonyl.

、この反応は通常溶媒中で行なわれ、溶媒としてはメタ
ノール、エタノール、プロパツール、ブタノール、イソ
プロピルアルコール等のアルコール、アセトニトリル、
塩化メチレン、ジメチルホルムアミド、ジメチルスルホ
キザイド、ノオキザン、テトラヒドロフラン等が例示さ
れる。反応温度は通常冷却下ないし室温で行なわれろ。
This reaction is usually carried out in a solvent, such as alcohols such as methanol, ethanol, propatool, butanol, isopropyl alcohol, acetonitrile,
Examples include methylene chloride, dimethylformamide, dimethylsulfoxide, nooxane, and tetrahydrofuran. The reaction temperature is usually carried out under cooling or at room temperature.

なお、前記の一般式(In)においてxlがハロゲン、
スルフィノ基またはスルホ基である化合物を原料物質と
して使用する場合には、トリエチルアミン、ピリジン、
N−メチルアニリン、1.5−ジアザビシクロ[5,4
,0]−5−ウンデセン等の塩基の存在下に反応を行な
うのが好ましく、また、前記の一般式(III)におい
てxlがメルカプト基であ・る化合物を原料物質として
使用する場合には、水銀、銀、鉛等の重金属化合物の存
在下に反応を行なうのが好ましい。また、原料化合物(
III)のうち、Xlがスルフィノ基またはスルホ基で
ある化合物は塩の形で使用することもでき、そのような
塩としてはナトリウム、カリウム等のアルカリ金属塩、
1.5−ジアザビシクロ[5,4,0L−5ウンデセン
塩等がその代表例として挙げられる。
In addition, in the above general formula (In), xl is halogen,
When using a compound with a sulfino group or a sulfo group as a raw material, triethylamine, pyridine,
N-methylaniline, 1,5-diazabicyclo[5,4
,0]-5-undecene or the like, and when a compound in which xl is a mercapto group in the general formula (III) is used as a raw material, Preferably, the reaction is carried out in the presence of a heavy metal compound such as mercury, silver or lead. In addition, the raw material compound (
Among III), compounds in which Xl is a sulfino group or a sulfo group can also be used in the form of a salt, and such salts include alkali metal salts such as sodium and potassium salts,
Representative examples include 1,5-diazabicyclo[5,4,0L-5 undecene salt and the like.

この発明の方法により生成するイミダゾール誘導体(1
)は常法により反応混合物から単離し、精製することが
でき、また遊離の化合物(1)は常法により塩酸塩の如
き所望の塩に導いてもよい。
Imidazole derivative (1) produced by the method of this invention
) can be isolated from the reaction mixture and purified by a conventional method, and the free compound (1) may be converted into a desired salt such as a hydrochloride by a conventional method.

なお、この発明の方法で使用される原料化合物はいずれ
も実施例に記載の方法またはそれらと同様の方法により
製造することができろ。
Incidentally, all of the raw material compounds used in the method of the present invention can be produced by the methods described in the Examples or by methods similar thereto.

次に、この発明の方法を実施例により説明する。Next, the method of the present invention will be explained using examples.

実施例1 (1)  シアナミド(18,59)およびN−シアノ
S−メチル−N’−[2−(5−メチルイミダゾールー
4−イルメチルチオ)エヂル]イソチオ尿素(lO,7
6g)を金属ナトリウム(1,019)のエタノール溶
液(+2010に加え、得られる混合物を15時間加熱
還流する。反応液を減圧下に濃縮し、残渣を冷水(50
WC)に加え、10%塩酸でpl−145に調整したの
ち、水浴中で1時間冷却する。析出物を濾取し、水洗、
乾燥すると、粗生成物(7439)を得る。本品をエタ
ノールと水の混液(ll)から再結晶すると、mp18
3−186°CのNN−ツノアノ−N”−[2−(5−
メチルイミダゾール−4−イルメチルチオ)エチル]グ
アニノン(5,179)を得る。収率49.2%。
Example 1 (1) Cyanamide (18,59) and N-cyanoS-methyl-N'-[2-(5-methylimidazol-4-ylmethylthio)edyl]isothiourea (lO,7
6 g) of sodium metal (1,019) was added to an ethanol solution (+2010
WC) and adjusted to pl-145 with 10% hydrochloric acid, and then cooled in a water bath for 1 hour. Filter the precipitate, wash with water,
Upon drying, the crude product (7439) is obtained. When this product is recrystallized from a mixture of ethanol and water (ll), the mp18
3-186°C NN-Anno-N”-[2-(5-
Methylimidazol-4-ylmethylthio)ethyl]guaninone (5,179) is obtained. Yield 49.2%.

元素分析 C,、I−1,3N7S 計算値: C45,61,1−14,98,N37.2
4.S12.18実験値 C45,59,H4,99N
36.51 S12.17[1え(ヌノヨール) νmax: 3330.3110.2660,2170
.1575,1518.14351378134813
101230867ca ’NMR(DMSOda+D
to) δ:2.32(3H,s)、2.4−2.7(211,
m)。
Elemental analysis C,, I-1,3N7S Calculated value: C45,61,1-14,98,N37.2
4. S12.18 experimental value C45,59,H4,99N
36.51 S12.17[1e(Nunoyor) νmax: 3330.3110.2660,2170
.. 1575, 1518.14351378134813
101230867ca'NMR(DMSOda+D
to) δ: 2.32 (3H, s), 2.4-2.7 (211,
m).

3.26 (2H,L、 J = 71(z)3.83
(21(、s)、8.77(IH,5)(2)上記で得
たN、N’−ジンアノ−N”−[2(5−メチルイミダ
ゾール−4−イルメチルチオ)エチル]グアニノン(5
27ff9)をメチルアミンのエタノール溶液(40%
、3.1g)に加え、室温で47時間撹拌する。反応液
を減圧下に濃縮し、残置をアセトニトリルで粉末化する
。不溶の原料物質を濾去し、濾液を減圧下に濃縮する。
3.26 (2H,L, J = 71(z)3.83
(21(,s), 8.77(IH,5) (2) N,N'-Zineano-N''-[2(5-methylimidazol-4-ylmethylthio)ethyl]guaninone (5
27ff9) in an ethanol solution of methylamine (40%
, 3.1 g) and stirred at room temperature for 47 hours. The reaction solution was concentrated under reduced pressure, and the residue was pulverized with acetonitrile. Undissolved starting material is filtered off and the filtrate is concentrated under reduced pressure.

残渣を7リカゲル・クロマトグラフィに付し、アセトニ
トリルとメタノールの混液(ll+)で溶出する。溶出
液を減圧下に濃縮し、濃縮液をシリカゲル薄層クロマト
グラフィ[展開溶媒、酢酸エチルとメタノールと28%
アンモニア水の混液(10・I:1)]に付し、さらに
アセトニトリルから再結晶すると、mp135−137
°CのN”−ノアノーN−メチルN’−[2−(5−メ
チルイミダゾール−4−イルメチルチオ)エチル]グア
ニノン(1,0x9)を得ろ。
The residue is chromatographed on 7 silica gel and eluted with a mixture of acetonitrile and methanol (11+). The eluate was concentrated under reduced pressure, and the concentrated solution was subjected to silica gel thin layer chromatography [developing solvent: 28% ethyl acetate and methanol.
A mixture of aqueous ammonia (10.I:1)] and recrystallized from acetonitrile yielded mp135-137.
Obtain N''-noanor N-methyl N'-[2-(5-methylimidazol-4-ylmethylthio)ethyl]guaninone (1,0x9) at °C.

実施例2 (1)  2−(5−メチルイミダゾール−・1−イル
メチルチオ)エチルイソチオノアネート・(その塩酸塩
から製造)(4、17y)のクロロ中ルム溶液(20m
Q)を、ノアナミド(1,05y)および1.5−ノア
ザヒンクロ[5,4,03−5−ウンデセン(3809
)のクロロ71;ルム溶液(50ffC)に加え、−夜
撹拌する。反応液を濃縮後、残渣を水(30ffQ)に
溶解し、エーテルで洗浄し、活性炭で処理したのら、水
冷下に10%塩酸でpI−15に調整4″る。析出物を
濾取し、水洗、乾燥すると、mp158〜161℃のN
−シアノ−N”[2−(5〜メチルイミダゾール−4−
イルメチルチオ)エチルコチオ尿素の1水和物(3,5
711)を得ろ。
Example 2 (1) A solution of 2-(5-methylimidazol-.1-ylmethylthio)ethyl isothionoanate (prepared from its hydrochloride) (4,17y) in chloro (20 m
Q) with noanamide (1,05y) and 1,5-noazahinculo[5,4,03-5-undecene (3809
) to the chlorolum solution (50ffC) and stirred overnight. After concentrating the reaction solution, the residue was dissolved in water (30ffQ), washed with ether, treated with activated carbon, and adjusted to pI-15 with 10% hydrochloric acid under water cooling. The precipitate was collected by filtration. , washed with water and dried, N of mp158-161℃
-cyano-N”[2-(5-methylimidazole-4-
ylmethylthio)ethylcothiourea monohydrate (3,5
711).

元素分析 Ce H13N 5S 2・I−1、0計算
値: C39,54,115,53,N25.62.S
23.46実験値 C39,71,I! 5.44. 
N 2569. S 22.73In(ヌノヨール) vmax: 3400327031302760265
0.2190.165215401470.14301
381.1362,1278.12371217120
511Q31088967831cm ’NMR(DM
SO−d、+−D、O) 62.32(311,s)、2.4−2.8(21−1
m)3.0−3.67(2+−(1m)、3.87(2
H,s)8.9.’3(IH,5) (2) 上記で得たN−シアノ−N’−[2−(5メヂ
ルイミダゾール−4−イルメチルチオ)エチ小素チオ尿
木の1水和物(765ffg)の塩化メチレン溶液(7
i12)に乾燥塩化水素ガスを水冷下に数分間導入した
のち、5塩化燐(1,259)を加え、室温で3時間撹
拌する。N”−ノアノーN−[1−(5メチルイミダゾ
ール−4−イルメチルチオ)エチル]クロロポルムアミ
ノンを含むこの反応混合物を濃縮し、濃縮液を塩化メチ
レン(5肩Q)で希釈したのち、−5℃に冷却する。こ
れにメチルアミンのエタノール溶液(40%、15II
C)を30℃以下で加え、室温で20時間ri、拌する
。この反応混合物を濾過し、濾液を濃縮ずろ。濃縮液を
アセトニトリルで希釈し、再び濾過する。dと液を濃縮
乾固し、残渣をカラムクロマトグラフィ[シリカゲル・
アセトニトリル−メタノール(4:1)]に付し、さら
に薄層クロマトグラフィ[シリカゲル・展開溶媒:酢酸
エチル−メタノール−28%アンモニア水(10:l:
l)]に付して精製したのち、アセトニトリルから再結
晶すると、mp136.5〜138℃のN”−シアノ−
N−メチル−N’ −[2−(5メチルイミダゾール−
4−イルメチルチオ)エヂル]グアニジン(10,4m
l?)を得る。収率1.5%。
Elemental analysis Ce H13N 5S 2・I-1, 0 calculated value: C39,54,115,53,N25.62. S
23.46 Experimental value C39,71,I! 5.44.
N2569. S 22.73In (Nunoyol) vmax: 3400327031302760265
0.2190.165215401470.14301
381.1362, 1278.12371217120
511Q31088967831cm'NMR(DM
SO-d, +-D, O) 62.32 (311, s), 2.4-2.8 (21-1
m) 3.0-3.67(2+-(1m), 3.87(2
H,s)8.9. '3(IH,5) (2) The monohydrate (765ffg) of N-cyano-N'-[2-(5medylimidazol-4-ylmethylthio)ethylthiourine obtained above Methylene chloride solution (7
After introducing dry hydrogen chloride gas into i12) for several minutes while cooling with water, phosphorus pentachloride (1,259) is added and stirred at room temperature for 3 hours. After concentrating the reaction mixture containing N''-noanorN-[1-(5methylimidazol-4-ylmethylthio)ethyl]chloropolmaminone and diluting the concentrate with methylene chloride (5-shoulder Q), - Cool to 5° C. Add methylamine in ethanol (40%, 15II
Add C) below 30°C and stir at room temperature for 20 hours. Filter the reaction mixture and concentrate the filtrate. Dilute the concentrate with acetonitrile and filter again. d and the liquid were concentrated to dryness, and the residue was subjected to column chromatography [silica gel
acetonitrile-methanol (4:1)] and further thin layer chromatography [silica gel, developing solvent: ethyl acetate-methanol-28% aqueous ammonia (10:1:
1)] and then recrystallized from acetonitrile to obtain N''-cyano-
N-methyl-N'-[2-(5methylimidazole-
4-ylmethylthio)edyl]guanidine (10,4m
l? ). Yield 1.5%.

特許出願人 スミスクライン・コーポレイション手続ネ
市正書 (方式) 1、事件の表示 平成 1年  特許願  第114018号2、発明9
名称 イミダゾール誘導体の製造法 3、補正をする者 事件との関係 特許出願人 名称 スミスクライン・コーポレイション4、代理人
Patent Applicant: SmithKline Corporation Procedures Official Document (Method) 1. Indication of the Case 1999 Patent Application No. 114018 2. Invention 9
Name: Process for producing imidazole derivatives 3, relationship with the amended case Name of patent applicant: SmithKline Corporation 4, agent

Claims (1)

【特許請求の範囲】[Claims] (1)一般式 ▲数式、化学式、表等があります▼ [式中、R^1は低級アルキル基、R^2およびR^3
は低級アルキレン基、X^1はハロゲン、メルカプト基
、シアナミド基、窒素含有5員芳香複素環−N−イル基
または式−S(O)_n−Z(ここでZはヒドロキシ基
またはアルキル基、nは1または2をそれぞれ意味する
)で示される基をそれぞれ意味する] で示される化合物に一般式 R^4−NH_2 (式中、R^4は低級アルキル基を意味する)で示され
る化合物を作用させて一般式 ▲数式、化学式、表等があります▼ (式中、R^1、R^2、R^3およびR^4は前と同
じ意味) で示されるイミダゾール誘導体を得ることを特徴とする
イミダゾール誘導体の製造法。
(1) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, R^1 is a lower alkyl group, R^2 and R^3
is a lower alkylene group, n means a group represented by 1 or 2, respectively] Compounds represented by the general formula R^4-NH_2 (wherein R^4 means a lower alkyl group) to obtain the imidazole derivative represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R^1, R^2, R^3 and R^4 have the same meanings as before) Characteristic method for producing imidazole derivatives.
JP1114018A 1989-05-01 1989-05-01 Production of imidazole derivative Granted JPH0285260A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1114018A JPH0285260A (en) 1989-05-01 1989-05-01 Production of imidazole derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1114018A JPH0285260A (en) 1989-05-01 1989-05-01 Production of imidazole derivative

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP8624979A Division JPS5610175A (en) 1979-07-06 1979-07-06 Preparation of imidazole derivative

Publications (2)

Publication Number Publication Date
JPH0285260A true JPH0285260A (en) 1990-03-26
JPH0567623B2 JPH0567623B2 (en) 1993-09-27

Family

ID=14626990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1114018A Granted JPH0285260A (en) 1989-05-01 1989-05-01 Production of imidazole derivative

Country Status (1)

Country Link
JP (1) JPH0285260A (en)

Also Published As

Publication number Publication date
JPH0567623B2 (en) 1993-09-27

Similar Documents

Publication Publication Date Title
US4381395A (en) Process for preparing an imidazole derivative
JPH03153689A (en) Preparation of aqueous solution of 5-methyl- n-(aryl)-1, 2, 4-triazol (1, 5-a) pyrimidine- 2-sulfonamide
EP0031388B1 (en) Process for preparing imidazole derivatives
EP0028936B1 (en) 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
JPH0285260A (en) Production of imidazole derivative
JPH0579061B2 (en)
US4292431A (en) Process for the production of hydroxymethylimidazoles
EP1979309A2 (en) Process for the preparation of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides and intermediates used therein
JPS596308B2 (en) Tetrazole thiol derivative
IL27897A (en) Preparation of pyrazinoylguanidines and pyrazinamidoguanidines
JPS5980685A (en) N-lower alkanoylguanine derivative and its use
CA2207464A1 (en) Crystal of n-{(quinolin-2-yl)phenylsulfonamides and process for producing the same
US5041660A (en) Novel alpha-chloroketone derivative and process for preparation thereof
GB1596376A (en) 4,5-disubstituted imidazole-2-thiones processes for their preparation and their use as intermediates
JPH01258683A (en) Production of 7-1d(-1) alpha-amino-alpha-(p- hydroxyphenyl)acetamide/-3-(1, 2, 3-triazol-4 (5)-thiomethyl-3-cephem-4-carboxylic acid 1, 2-propylene glycol and novel intermediate
JPH0678291B2 (en) Process for producing cyano-substituted enol ether
JPH0285261A (en) Production of imidazole derivative
JPH0477474A (en) Production of 6-amino-3-chloropyridazine
CN107365299B (en) Preparation method of dabigatran etexilate and intermediate thereof
JPS6144854A (en) N-dichloroalkylbenzoic acid amide and manufacture
JPS5914036B2 (en) New method for producing rifamycin SV derivatives
KR970004048B1 (en) Separation method of diastereomer of asymmetric 3-methoxymethyl cephalosporin derivative
JPH03251573A (en) Production of cimetidine
JPH0812658A (en) Production of sydnones
JPH03161475A (en) Production of tetrahydronaphthalene derivative